Claudia C. Meurs
Zevenaar, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
External validation of precisebreast, a digital prognostic test for predicting breast cancer recurrence, in an early-stage cohort from the Netherlands.
Journal: Breast cancer research : BCR
Published: May 19, 2025
ASO Author Reflections: Sentinel Lymph Node Biopsy for Patients with a Non-classic Lobular Carcinoma In Situ Breast Biopsy.
Journal: Annals of surgical oncology
Published: December 18, 2024
Estrogen-Receptor Loss and ESR1 Mutation in Estrogen-Receptor-Positive Metastatic Breast Cancer and the Effect on Overall Survival.
Journal: Cancers
Published: August 06, 2024
Surgery for Classic, Pleomorphic and Non-classic Lobular Carcinoma In Situ: Surgery Rate, Risk of Upstaging and Short-Term Follow-Up.
Journal: Annals of surgical oncology
Published: July 30, 2024
ASO Author Reflections: What Can Prediction Models for Upstaging of DCIS Diagnosed on Biopsy Tell Us About DCIS Surveillance Trials?
Journal: Annals of surgical oncology
Published: January 08, 2024
Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ.
Journal: Annals of surgical oncology
Published: January 19, 2023
Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model.
Journal: Annals of surgical oncology
Published: November 15, 2022
RE: Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ.
Journal: JNCI cancer spectrum
Published: June 23, 2020
A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers.
Journal: British journal of cancer
Published: April 06, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026